EiR Blog

Immuno Oncology CRO Trials play an important role in improving personalised cancer treatment. Essentially, a trial is an evaluation of a new therapy or a new combination of therapies to see if it might be a useful and helpful approach to treating cancer. Almost any therapy a cancer patient receives is in some sense a trial to see if it actually helps and benefits the patients in controlling the cancer and this is measured usually by radiographs, CT scans or other kinds of scans to see if the cancer is actually being controlled. Immuno Oncology CRO trials occur in different phases and generally Phase 1 trials involve taking a brand new drug or a new combination of drugs to determine which the safe and tolerable dose of the drug is. Phase 1 trials are about testing safety. A combination of drugs may also be tested to determine, what is the...